from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2128/-

LFCtreatmentdescriptionclass of inhibitor

-2.081

Amikacinug/mL Amikacintranslation

-1.477

Cap5-10ug/mL Capreomycintranslation

-1.341

Rox10-50 ug/mL Roxithromycintranslation

-0.116

SM2-5 ug/mL Streptomycintranslation

-1.820

Tet5-10 ug/mL Tetracyclinetranslation

-0.324

Rif0.2-5ug/mL Rifampicintranscription

-1.003

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.526

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.165

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.037

CPZ10-50 ug/mL Chlorpromazinerespiration

0.847

Clofazimine10-13 ug/mL Clofaziminerespiration

0.846

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.894

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.621

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.089

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.962

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.302

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.058

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.185

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.438

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.846

KCN5-20 ug/mL Potassium cyaniderespiration

0.416

NaN30.2-2 mM Sodium aziderespiration

1.173

Nigericin50 uM Nigericinrespiration

-0.817

TRC10-150 ug/mL Triclosanrespiration

-1.285

TRZ10-25 ug/mL Thioridazinerespiration

-2.555

Valinomycin0.5-10 uM Valinomycinrespiration

1.418

ZnSO42 mM ZnSO4respiration

0.783

menadione6-10 ug/mL Menadionerespiration

0.323

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.806

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.342

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.918

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.483

NRP_1Non-replicating persistence stage 1dosRassociated

0.776

Amp0.2mg/mL AmpicillincellWall

0.321

Cephalexin20-100 ug/mL CephalexincellWall

0.908

Cerulenin0.32-5 ug/mL CerulenincellWall

0.301

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.406

EMB10-20 ug/mL EthambutolcellWall

0.482

Eta12-40 ug/mL EthionamidecellWall

0.568

INH0.2-0.4 ug/mL IsoniazidcellWall

0.386

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.690

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.559

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.641

BZA0.12 mg/mL BenzamidearomaticAmides

-0.655

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.394

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.361

H2O24 mM hydrogen peroxideDNAdamaging

0.292

Levo10 ug/mL LevofloxacinDNAdamaging

0.343

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.487

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.519

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.277

UVUV-irradiationDNAdamaging

-0.012

ARP41-4 ug/mL Antitubercular compound ARP4?

0.384

Antimycin12.5-50 ug/mL Antimycin A?

1.193

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.474

PA_110-50 ug/mL Antitubercular compound PA-1?

0.222

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.096

PA8240.2-2 ug/mL PA-824?

0.013

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.882

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.536

Verapamil50 uM Verapamil?

1.040

mercaptoethanol2 mM 2-Mercaptoethanol?

0.880

methoxatin10-20 ug/mL Methoxatin?